DK1510580T3 - Trunkeret hepatitis C E2-polypeptid og fremgangsmåder til opnåelse heraf - Google Patents

Trunkeret hepatitis C E2-polypeptid og fremgangsmåder til opnåelse heraf

Info

Publication number
DK1510580T3
DK1510580T3 DK04077562T DK04077562T DK1510580T3 DK 1510580 T3 DK1510580 T3 DK 1510580T3 DK 04077562 T DK04077562 T DK 04077562T DK 04077562 T DK04077562 T DK 04077562T DK 1510580 T3 DK1510580 T3 DK 1510580T3
Authority
DK
Denmark
Prior art keywords
polypeptide
obtaining
methods
polypeptides
truncated
Prior art date
Application number
DK04077562T
Other languages
English (en)
Inventor
Mark Selby
Michael Houghton
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Priority claimed from PCT/US1995/010035 external-priority patent/WO1996004301A2/en
Application granted granted Critical
Publication of DK1510580T3 publication Critical patent/DK1510580T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK04077562T 1994-07-29 1995-07-26 Trunkeret hepatitis C E2-polypeptid og fremgangsmåder til opnåelse heraf DK1510580T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28295994A 1994-07-29 1994-07-29
US50660895A 1995-07-25 1995-07-25
PCT/US1995/010035 WO1996004301A2 (en) 1994-07-29 1995-07-26 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same

Publications (1)

Publication Number Publication Date
DK1510580T3 true DK1510580T3 (da) 2009-02-16

Family

ID=26961777

Family Applications (2)

Application Number Title Priority Date Filing Date
DK95928779T DK0773957T3 (da) 1994-07-29 1995-07-26 Udskilt hepatitis C-virus-E1/E2-kompleks opnået fra C-terminalt trunkerede E1- og E2-polypeptider
DK04077562T DK1510580T3 (da) 1994-07-29 1995-07-26 Trunkeret hepatitis C E2-polypeptid og fremgangsmåder til opnåelse heraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK95928779T DK0773957T3 (da) 1994-07-29 1995-07-26 Udskilt hepatitis C-virus-E1/E2-kompleks opnået fra C-terminalt trunkerede E1- og E2-polypeptider

Country Status (12)

Country Link
US (1) US6326171B1 (da)
EP (2) EP1510580B1 (da)
JP (4) JP3793571B2 (da)
AT (2) ATE298764T1 (da)
CA (1) CA2195312A1 (da)
DE (2) DE69535899D1 (da)
DK (2) DK0773957T3 (da)
ES (2) ES2316920T3 (da)
IL (3) IL114775A (da)
MX (1) MX9700677A (da)
MY (1) MY121563A (da)
PT (1) PT1510580E (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE437951T1 (de) * 1997-05-06 2009-08-15 Novartis Vaccines & Diagnostic Intrazelluläre herstellung von verkürztem hepatitis c-polypeptid e2
ATE413190T1 (de) * 1999-12-01 2008-11-15 Novartis Vaccines & Diagnostic Hervorrufen von antikörpern spezifisch für hepatitis c virus (hcv)
US7439042B2 (en) * 2002-12-16 2008-10-21 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis C infection
CN101437964B (zh) * 2004-10-18 2012-06-13 全球免疫股份有限公司 基于酵母的对慢性丙型肝炎感染的治疗
US9758794B2 (en) 2008-04-22 2017-09-12 Rutgers, The State University Of New Jersey HCV E2 construct compositions and methods
US20110091495A1 (en) * 2008-04-22 2011-04-21 Rutgers, The State University Of New Jersey Hcv e2 construct compositions and methods
US8728489B2 (en) 2008-09-19 2014-05-20 Globeimmune, Inc. Immunotherapy for chronic hepatitis C virus infection
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN105621806B (zh) * 2016-01-22 2018-10-30 南京贝克特环保科技有限公司 一种快速处理餐厨垃圾废水的生物聚沉氧化工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU220204B (hu) 1987-11-18 2001-11-28 Chiron Corp. HCV polipeptidek és HCV polinukleotidok, ilyen polinukleotidokat tartalmazó vektorok és ezekkel transzformált gazdasejtek, valamint HCV fertőzés kimutatására szolgáló diagnosztikumok és immunvizsgálati készlet
HU225068B1 (en) 1989-03-17 2006-05-29 Chiron Corp Process for producing diagnostics and vaccine of nanbh
GEP20002164B (en) 1989-05-18 2000-07-10 Novartis Vaccines & Diagnostic Oligomers, method for detecting of hcv sequence, kit for its detecting, method for production of the blood free from hcv
JPH06501845A (ja) 1990-08-02 1994-03-03 カイロン　コーポレイション バキュロウイルス―昆虫細胞発現システムを用いたヒトｃｍｖ糖タンパク質―ｈの発現
ATE188220T1 (de) 1990-11-08 2000-01-15 Chiron Corp Asiloglycoproteine des hepatitis c-virus
US6274148B1 (en) * 1990-11-08 2001-08-14 Chiron Corporation Hepatitis C virus asialoglycoproteins
BR9506059A (pt) 1994-07-29 1997-10-28 Innogenetics Nv Proteinas envelopes purificadas de virus c para uso de diagnóstico e terapêutico

Also Published As

Publication number Publication date
DK0773957T3 (da) 2005-10-24
EP0773957A2 (en) 1997-05-21
JP2005290010A (ja) 2005-10-20
JP2007291126A (ja) 2007-11-08
MX9700677A (es) 1997-04-30
IL114775A (en) 2006-12-10
JP4298735B2 (ja) 2009-07-22
DE69534296T2 (de) 2006-04-27
ATE417109T1 (de) 2008-12-15
PT1510580E (pt) 2009-02-18
JP2007006901A (ja) 2007-01-18
EP1510580B1 (en) 2008-12-10
DE69534296D1 (de) 2005-08-18
EP0773957B1 (en) 2005-06-29
ATE298764T1 (de) 2005-07-15
IL185119A0 (en) 2007-12-03
JP3793571B2 (ja) 2006-07-05
ES2316920T3 (es) 2009-04-16
EP1510580A2 (en) 2005-03-02
DE69535899D1 (de) 2009-01-22
ES2244965T3 (es) 2005-12-16
US6326171B1 (en) 2001-12-04
JP2002515005A (ja) 2002-05-21
EP1510580A3 (en) 2005-06-22
IL137840A0 (en) 2001-10-31
MY121563A (en) 2006-02-28
CA2195312A1 (en) 1996-02-15

Similar Documents

Publication Publication Date Title
WO1996004301A3 (en) Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
IL185119A0 (en) Method of producing a secreted hcv polypeptide
DE3788626T2 (de) Nor-Statin und Nor-Cyclostatin enthaltende Polypeptide.
NO870668D0 (no) Fremgangsmaate for gjenvinning av mikrobielt fremstilt rekombinant.
ATE236981T1 (de) Von menschlichen t-zellen immunodominante epiropen des virus der c-hepatitis
DE68905119T2 (de) Methode zur kontrolle von pneumocystis carinii.
DE68912268T2 (de) Elastomere polypeptide als vaskulare prothesematerialien.
DE3786767D1 (de) Neues polypeptid.
DE68909179T2 (de) Verschlusselement zur Kontrolle von Ileokolostomie.
DE3888921D1 (de) Polypeptide.
DK295188D0 (da) Fibronectinbindende protein og fremgangsmaade til fremstilling heraf
DE69715181T2 (de) Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
FI841288A0 (fi) Rekombinant-dna-kod foer uttryckning av polypeptid.
ATE225806T1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
ATE291080T1 (de) Von humanem lipase-ähnlichem gen kodierte polypeptide, sowie zusammensetzungen und methoden
NO873216D0 (no) Rekombinante htlv-iii-proteiner og anvendelse derav.
DE69435098D1 (de) Neuartige polypeptide und dafür kodierende dna
NO970113L (no) Kollagenbindende protein eller polypeptid
NO890174D0 (no) Rekombinante interleukin-1alfa-polypeptider.
NO961086D0 (no) Nye proteiner/polypeptider og kotransfeksjonsplasmider og levende rekombinante bærere for disse
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
NO891485D0 (no) Fremgangsmaate til fremstilling av 22 kd-sgh-protein og lineaer genevektor.
ATE99324T1 (de) Nor-statin und nor-cyclostatin enthaltende polypeptide.
FI894215A0 (fi) Poliovirus polypeptid.